You have no items in your shopping cart.
Drug Pipeline Updates
In this section you will find Publication Series Analytical Tool Drug Pipeline Updates market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities in the biotech, life science and pharmaceutical industries.
| Items 1 to 10 of 28 total | Page: | Show per page |
| View as: List Grid |
Sort by
|
Colorectal Cancer Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 270 (234) companies plus partners developing 330 (270) drugs targeting colorectal cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 141 (110) drugs. Colorectal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 187 (155) different targets. Learn More
Breast Cancer Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 304 (268) companies plus partners developing 417 (360) drugs targeting breast cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 155 (116) drugs. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 207 (180) different targets. Learn More
Angiogenesis in Oncology Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 228 (191) companies plus partners developing 241 (197) angiogenesis drugs in 865 (520) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 125 (92) drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 175 (148) different targets. Learn More
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 235 (191) companies plus partners developing 432 (359) PKI drugs in 1233 (897) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 222 (135) drugs. Protein Kinase Inhibitors In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 171 (133) different targets. Learn More
Lung Cancer Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 298 (265) companies plus partners developing 399 (352) lung cancer drugs in 455 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 166 (117) drugs. Lung Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 221 (181) different targets. Learn More
Cancer Vaccines Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 195 (165) companies plus partners developing 218 (194) cancer vaccine drugs in 360 (284) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 175 (149) drugs. Cancer Vaccines Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 97 (84) different targets. Learn More
Lymphoma Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 179 (157) companies plus partners developing 255 (208) lymphoma drugs in 344 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 66 (50) drugs. Lymphoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 157 (123) different targets. Learn More
Antibodies in Oncology Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 248 (223) companies plus partners developing 489 (463) antibody drugs in 956 (820) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 287 (200) drugs. Antibodies In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 229 (195) different targets. Learn More
Immunotherapy in Oncology Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 2,450.00
There are today 421 (291) companies plus partners developing 824 (396) cancer immunotherapy drugs in 1612 (674) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 329 (178) drugs. Immunotherapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 315 (158) different targets. Learn More
Leukemia Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 222 (201) companies plus partners developing 280 (242) leukemia drugs in 402 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 84 (63) drugs. Leukemia Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 179 (148) different targets. Learn More
| Items 1 to 10 of 28 total | Page: | Show per page |
| View as: List Grid |
Sort by
|